Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol Sedation by Non-Anesthesiologists in Palliative Care
NCT02734511Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- May 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of propofol in refractory pain, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoints: success rate of care without severe pain for the patient at 2 hours and success rate of care without major side effects at 2 hours. Started May 2017; status: completed.
02
Drugs
propofol
03
Conditions
refractory pain
Beyond the preview
Go deeper on NCT02734511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734511.